期刊
EUROPEAN JOURNAL OF MEDICAL GENETICS
卷 64, 期 6, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejmg.2021.104231
关键词
Endoscopic retrograde; cholangiopancreatography (ERCP); Primary sclerosing cholangitis (PSC); Cholangiocarcinoma; Endoscopy; Single operator cholangioscopy (SOC)
资金
- Swedish Cancer Society
- Stockholm County Council
- Cancer Research Funds of Radiumhemmet
PSC is a rare liver disease that causes biliary strictures and neoplastic development, with ERCP being the primary management strategy.
Primary sclerosing cholangitis (PSC) is a rare, inflammatory cholestatic liver disease that causes biliary strictures which can lead to secondary complications. About 30-50% of PSC patients develop dominant strictures (DS) in the biliary tree, which are both the cause of jaundice and bacterial cholangitis as well as predilection spots for development of neoplastic development. Cancer is the most common cause of death in PSC. A central concern is to distinguish malignant from benign strictures, which eventually is done by invasive methods to obtain a brush cytology or biopsy sample, in most cases via endoscopic retrograde cholangiography-pancreatography (ERCP). Since medical therapies, like ursodesoxycholic acid or immunosuppressive drugs have no proven effect, therapeutic ERCP has become the primary management strategy to improve symptoms and in some patients may slow down disease progression. This article aims at outlining the current and emerging methods in ERCP in PSC patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据